Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norwegian Cruise Line Holdings Ltd vs Tempus AI — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $15.54 (market cap $6.91B), while Tempus AI trades at $70.04 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Norwegian Cruise Line Holdings Ltd for 68 Days and Tempus AI for 22 Days on average.
| NCLH | TEM | |
|---|---|---|
Market Cap | $6.91B | $12.77B |
Volume | 25,654,210 | 8,980,490 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $25.02 | $99.28 |
52-Week Low | $14.12 | $41.55 |
Typical Hold Time | 68 Days | 22 Days |
Enterprise Value | $21.73B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Norwegian Cruise Line Holdings (NCLH) trades at $15.49, down 0.13% on the day, with a neutral technical signal and bearish moving averages. The company reported strong recent earnings beats and expects Q3 2026 results to exceed guidance, with revenue growth from $9.8B in 2025 to $10.2B projected for 2026. Valuation metrics appear attractive with a P/E of 9.12 and P/S of 0.72, while analyst consensus remains bullish with a $20.86 price target.
NCLH presents a compelling value opportunity with solid fundamentals and positive earnings momentum, though investors face risks from high debt levels, yield pressure, and competitive industry dynamics. The stock's current discount to analyst targets suggests potential upside if operational improvements continue.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
